CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
496.60 -3.09(-0.62%) NAV as on 29 Apr 2025
3.17 % 1 M
15.44 % 1 Y
20.01 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.82

As on 31 Mar, 2025
age-icon Age :

20 yrs 10 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

8,080.97 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.65

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2025
Others 0.54 %
Equity 99.46 %

TOP HOLDINGS

Sun Pharmaceutical Industries...13.43 %
Divi's Laboratories Ltd.9.28 %
Lupin Ltd.7.27 %
Cipla Ltd.5.71 %
Apollo Hospitals Enterprise Ltd.5.31 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs80.62
Hospital & Healthcare Services17.82
Business Support1.01
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)250.18290.14270.59428.87481.27
Net Assets(Rs Crores) (as on 31-Mar-2025) 4260.99 4931.89 4304.46 7125.28 8080.97
Scheme Returns(%)(Absolute)77.3614.83-6.8558.2410.94
B'mark Returns(%)(Absolute)NANANANANA
Category Rank32/7543/7565/7617/9030/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity496.60-3.09(-0.62%)NAV As on 29 Apr, 202505-Jun-2004Inception Date8,080.97AUM In Cr.15.44%1Y20.01%3Y22.50%5Y20.53%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.27-0.28(-0.75%)NAV As on 29 Apr, 202513-Jul-2018Inception Date4,914.64AUM In Cr.20.77%1Y24.16%3Y25.01%5Y21.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity420.24-2.22(-0.53%)NAV As on 29 Apr, 202514-Jul-1999Inception Date3,610.51AUM In Cr.20.63%1Y23.83%3Y24.41%5Y16.32%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.30-0.28(-0.93%)NAV As on 29 Apr, 202528-Dec-2015Inception Date1,183.65AUM In Cr.15.75%1Y20.26%3Y21.78%5Y12.19%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors